Wang Yuguang, Founder of Maxi Novel

Wang Yuguang is the CEO of Maxinovel Pharmaceuticals, a semi-virtual biotech company he founded in March 2016. Based in Beijing, China.

About Wang Yuguang

Wang Yuguang is the CEO of Maxinovel Pharmaceuticals, a semi-virtual biotech company he founded in March 2016. Maxinovel Pharmaceuticals aims to develop a pipeline of orally-active one-pill combinations of immuno-oncology (IO) therapy, targeted therapy, and chemotherapy to treat cancer. The company has global operations with a preclinical lab in Shanghai, a biomarker lab in Guangzhou, clinical operations in Sydney, and a US base in New Jersey. Prior to founding Maxinovel, Wang Yuguang accumulated three decades of industry experience across Big Pharma, biotech, and CRO organizations in China and the US, including working at Schering-Plough and Shanghai ChemPartner.

Wang Yuguang at a glance

More founders in Beijing, China (28)

Browse related founder lists (2)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades